SBA Administrator Kelly Loeffler Calls on California Governor Gavin Newsom to Request Disaster Declaration for Small Businesses Impacted by L.A. Riots
WASHINGTON, June 09, 2025 (GLOBE NEWSWIRE) -- Today, Kelly Loeffler, Administrator of the U.S. Small Business Administration (SBA), called on California Governor Gavin Newsom to request an SBA Economic Injury Disaster Loan (EIDL) Declaration to authorize the agency to begin delivering urgent assistance to small businesses across Los Angeles that have been ransacked by rioters since civil unrest began last week. The agency stands ready to deliver critical aid to innocent American victims – whose storefronts have been looted and destroyed by the migrant mob that is wreaking havoc in defense of criminal illegal aliens.
'We're giving Gavin Newsom the opportunity to stop siding with criminal illegal aliens and start siding with law-abiding Americans – many of whom have lost everything to the violent and destructive riots across Los Angeles,' said SBA Administrator Kelly Loeffler. 'The migrant mob has looted stores, destroyed storefronts, and committed criminal acts of vandalism against our small businesses. Although local leaders are allowing Los Angeles to burn, federal partners are ready to help American citizens rebuild – and we will do so, as soon as the Governor answers their call for help.'
For the safety of employees and small business owners, Administrator Loeffler recently announced that SBA would be relocating its Regional Office out of Los Angeles due to the city's refusal to cooperate with U.S. Immigration and Customs Enforcement (ICE). The Regional Office is located mere steps from the violence that continues to occur in downtown Los Angeles – and where U.S. Marines have been deployed to restore order.
The SBA has provided the state of California with all relevant information needed to request an EIDL Declaration – which will allow small businesses in Los Angeles to apply for low-interest, long-term loans of up to $2 million to help them rebuild following the catastrophic violence of this weekend. Given the urgency of the situation, the SBA is committed to approving any such disaster declaration as soon as it is submitted by Governor Newsom.
CONTACT: SBA HQ Press Team U.S. Small Business Administration press_office@sba.govSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Gavin Newsom Pokes Back After Fox News Hosts Critique His Social Media Style: ‘Stop Calling Me Daddy'
Sean Hannity and Jesse Watters bemoan the California governor's online behavior with Gov. Ron DeSantis and Sen. Ted Cruz Multiple Fox News hosts did not give Gov. Gavin Newsom a moment's rest on Wednesday night, dogpiling on his attempts at virality with his Trump-esque social media activity. 'A performative confrontational style — maybe it wins you points with the loony radical base in your party, but America is not going to vote for that record,' Sean Hannity said on his show. More from TheWrap Gavin Newsom Pokes Back After Fox News Hosts Critique His Social Media Style: 'Stop Calling Me Daddy' | Video 17 Senators Demand US Pressure Israel Over Killing Palestinian Journalists, Opening Gaza to Media Jack White: Being Insulted by Trump White House 'Is a Badge of Honor for Me' Advisor to NY Mayor Eric Adams Hands Reporter Cash – Hidden in a Bag of Potato Chips The California governor subtweeted a video of Hannity's comments, adding, 'Alllllllmost got it that time,' hinting that his social media activity is a parody of the president's attempts to woo his right-wing fan base. Fellow host Jesse Watters also discussed his antics with Florida Gov. Ron DeSantis, with Watters calling California 'a knife on wheels.' DeSantis, who debated Newsom in 2023, said that Newsom's obsession with President Donald Trump is distracting him from other political duties. 'Why is he spending all this time trying to be fresh with President Trump?' DeSantis asked. 'Why doesn't he do his job and protect the people?' In response to a banner overlaying the pair's conversation, Newsom wrote on X, 'Jesse, please stop calling me Daddy. It's disturbing.' The Fox News banner read: 'Dems look for Big Daddy Energy.' Texas Gov. Ted Cruz, meanwhile, sat down with Hannity on Wednesday and told him that he did not understand how the Democrats screwed up the natural resources and advantages the state had given to them. 'When I'm out there I look around and think, how did these people manage to screw this place up?' Cruz said. 'It's a combination of every bad left wing idea: it's out-of-control taxes; it's out-of-control regulations; it's out-of-control lawsuits.' 'Not to mention the illegals Gavin Newsom is letting in,' he added. 'If you're a murderer or a rapist, come to California. Gavin Newsom wants you to come to California.' Hannity did not, however, that he actually has a personal relationship with Newsom and finds him 'very likable' outside of politics. 'But unfortunately it is his radical policies — that is where the disaster is for him,' he said. 'Pretending to be President Trump is not only embarrassing, it will not negate the disastrous policies and positions and the horrible state California's in.' The post Gavin Newsom Pokes Back After Fox News Hosts Critique His Social Media Style: 'Stop Calling Me Daddy' | Video appeared first on TheWrap.
Yahoo
20 minutes ago
- Yahoo
Medical Device Testing Market Size Attains USD 24.32 Bn by 2034
The global medical device testing market is valued at USD 10.77 billion in 2025 and is projected to grow to approximately USD 24.32 billion by 2034, expanding at a CAGR of 9.47% during the forecast period. Ottawa, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global medical device testing market size was valued at USD 9.84 billion in 2024 and is projected to reach approximately USD 24.32 billion by 2034, expanding at a CAGR of 9.47% over the forecast period, according to a study published by Towards Healthcare, a sister firm of Precedence Research. A rise in the need for trustworthy and high-quality medical devices is propelling the expansion of the global market. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways Asia-Pacific led the global medical device testing market in 2024. North America is expected to witness rapid expansion during 2025-2034. By service, the biocompatibility tests segment was dominant in the market in 2024. By service, the chemistry tests segment is expected to register significant growth in the coming years. By phase, the clinical segment held the dominating share of the global medical device testing market in 2024. By phase, the preclinical segment is expected to grow at a notable CAGR during 2025-2034. Market Overview & Potential A process in which the evaluation of the safety, efficiency, and performance of medical devices is conducted, termed medical device testing. Across the globe, the global medical device testing market is experiencing growing regulatory strictness, technological breakthroughs, and a rising healthcare sector. In 2025, it comprises major developments in in-vitro diagnostics (IVD), and the execution of the EU's Medical Device Regulation (MDR) around the market. Usually, it encompasses the evaluation, functionality, durability, sterility, biocompatibility, electrical safety, and usability of the medical device. What are the Key Growth Drivers Involved in The Expansion of The Market? In 2025, several growth factors are impacting the overall development of the global medical device testing market. The growing geriatric population associated with chronic concerns is driving demand for diverse medical devices involved in diabetes management, mobility assistance, and remote patient monitoring. Along with this, an emerging strict regulatory landscape, such as the FDA and the EU's MDR, is offering strong testing guidelines for safety and efficacy. Majorly, different developing medical device producers, particularly startups, are highly outsourcing testing to specialized firms, resulting in market growth. Become a valued research partner with us - What are the Key Drifts Involved in the Market? In August 2025, BDC Laboratories, a leading player in cardiovascular device testing solutions, entered into a strategic partnership with the newly established Dilawri Cardiovascular Institute (DCI) to enhance focus on the development and clinical validation of cardiovascular medical devices. In October 2024, NAMSA, a leader in MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global player in medical technology, partnered to expand the regulatory approval and commercialization of Terumo's product portfolio. What is the Emerging Challenge in the Market? The need for significant investment in specialized equipment, skilled personnel, and ongoing compliance efforts is creating a major hindrance in the global medical device testing market. Alongside, the widespread requirement for specialized knowledge and skills in areas like biocompatibility, sterilization, and electrical safety is evolving into a barrier to the development of the market. Regional Analysis Why Did Asia Pacific Dominate the Market in 2024? Across the global medical device testing market, the Asia Pacific was dominant in 2024. China, India, and Japan are experiencing a vital expansion due to increasing economies and growing disposable incomes. This ultimately results in a rise in investment in the healthcare system and medical devices, propelling the adoption of various testing services. Additionally, faster advances in different technologies, such as miniaturization, digitalization, and the development of new materials, are enhancing the need for specialized testing March 2025, UL Solutions Inc., a major player in applied safety science, announced its expansion of Songshan Lake IoT Laboratory in Dongguan, China, to support manufacturers in navigating the complexities of connected product and wireless device testing and market access. What Made North America Significantly Grow in the Market in 2024? During 2025-2034, North America is predicted to expand at a rapid CAGR in the global medical device testing market. Merging high R&D investment by many medical device companies, like the adoption of technologies like AI and automation, in this region, is fueling overall market development. Also, North America is focusing on patient safety and regulatory compliance, especially in the US, which requires rigorous testing throughout the product January 2025, Argon Medical Devices enrolled the first patient in a US-based study exploring a newer catheter-based device for managing blood clots in the lungs. In June 2025, Ash, a leading at-home health testing platform, and Impilo, a leader in offering at-home healthcare, partnered to deliver feasible at-home health monitoring and testing nationwide. You can place an order or ask any questions, please feel free to contact us at sales@ Segmental Insights By service analysis Which Service Led the Medical Device Testing Market in 2024? The biocompatibility tests segment held the largest revenue share of the market in 2024. Around the globe, numerous medical device manufacturers are preferring biocompatibility testing to achieve market acceptance and develop a robust reputation for quality and safety. Along with this, these tests are important for reducing the risk of adverse reactions, infections, and other difficulties linked with medical devices. This leads to ensuring patient safety and improving device efficacy. Whereas the chemistry tests segment is predicted to grow rapidly during 2025-2034. Several advantages of this segment are the assessment of the possible toxicity of medical devices and confirming that they will not react negatively with the body. Additionally, the chemistry tests are widely employed in broader devices, from simple disposables to complex implants, to ensure their safety and regulatory compliance. Primarily, they comprise the identification of chemical compounds of a medical device and examination of probable risks linked with their presence, which further assist in biocompatibility assessment. By phase analysis How did the Clinical Segment Hold a Major Share of the Market in 2024? The clinical segment dominated the global medical device testing market in 2024. Usually, different phases of clinical trials offer significant real-world evidence that assists healthcare professionals in making informed decisions about device usage and expands the continuous optimization of medical devices. A surge in 3D printing and AI in medical device manufacturing is boosting the need for clinical trials to study the performance and safety of these new technologies. Also, the segment is driven by the accelerating need for advanced medical devices, a focus on patient safety and efficacy, and a rise in regulatory scrutiny. The preclinical segment is predicted to witness significant expansion in the studied years. Ongoing developments in biocompatibility testing, microbiology testing, and package validation are widely impacting the development of the preclinical phase of the market. Furthermore, various medical device industries, especially small-scale ones, have a shortage of resources or well-trained personnel to execute complete preclinical testing in-house. This further propels the demand for specialized preclinical testing service providers. Whereas, currently growing diverse chronic diseases are fueling demand for enhanced patient safety, which ultimately relies on the development of the preclinical phase. Get the latest insights on healthcare industry segmentation with our Annual Membership: Recent Developments In July 2025, Siemens Healthineers launched the CN-3000 and CN-6000 Hemostasis Systems for coagulation testing in Canada. In May 2025, Roche unveiled the Elecsys PRO-C3 test for the evaluation of the liver fibrosis severity in individuals with signs of metabolic dysfunction–associated steatotic liver disease (MASLD). In March 2025, Nelson Labs launched a groundbreaking rapid sterility testing to notably expedite product sterility results. In October 2024, UPM Biomedicals, the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications, introduced FibGel, a natural injectable hydrogel for permanent implantable medical devices. Medical Device Testing Market Key Players SGS SA Laboratory Corporation of America Holdings Nelson Laboratories, LLC TÜV SÜD Charles River Laboratories Element Minnetonka North America Science Associates Inc. (NAMSA) Eurofins Scientific Pace Analytical Services LLC Intertek Group Plc WuXi AppTec Browse More Insights of Towards Healthcare: The global medical device contract manufacturing market is valued at USD 78.61 billion in 2024, expected to grow to USD 87.14 billion in 2025, and projected to reach approximately USD 220.57 billion by 2034, expanding at a CAGR of 10.86% between 2025 and 2034. The global medical device outsourcing market is estimated at USD 160.3 billion in 2024, rising to USD 180.59 billion in 2025, and forecasted to hit nearly USD 507.89 billion by 2034, advancing at a CAGR of 12.65% during 2025–2034. The global pain management devices market stands at USD 7.68 billion in 2024, increasing to USD 8.41 billion in 2025, and is anticipated to reach around USD 19.1 billion by 2034, growing at a CAGR of 9.54% over the forecast period. The global medical device CRO market is valued at USD 8.49 billion in 2024, set to rise to USD 9.25 billion in 2025, and projected to surpass USD 19.9 billion by 2034, at a CAGR of 8.98% between 2025 and 2034. The global wearable medical devices market is calculated at USD 42.78 billion in 2024, climbing to USD 53.68 billion in 2025, and expected to surge to nearly USD 408.61 billion by 2034, registering a strong CAGR of 25.57% from 2025 to 2034. The global implantable medical devices market is estimated at USD 97.17 billion in 2024, growing to USD 103.14 billion in 2025, and forecasted to reach around USD 176.33 billion by 2034, advancing at a CAGR of 6.14% during 2025–2034. The medical device gaskets & seals market was valued at USD 0.92 billion in 2023 and is projected to expand to USD 1.57 billion by 2034, progressing at a CAGR of 5% from 2024 to 2034. The 3D-printed medical devices market is expected to grow from USD 5.59 billion in 2025 to approximately USD 24.69 billion by 2034, witnessing a robust CAGR of 17.94% over the forecast period. The global endoscopy devices market size is valued at USD 61.1 billion in 2024, projected to increase to USD 63.44 billion in 2025, and estimated to reach USD 88.55 billion by 2034, registering a CAGR of 3.82% between 2025 and 2034. The global rehabilitation equipment market is valued at USD 17 billion in 2024, expected to rise to USD 18.42 billion in 2025, and projected to hit USD 37.34 billion by 2034, expanding at a CAGR of 8.34% from 2025 to 2034. Segments Covered in The Report By Service Biocompatibility Tests Cardiovascular Device's Biocompatibility Tests Orthopedic Device's Biocompatibility Tests Dental Implant Devices' Biocompatibility Tests Dermal Filler's Biocompatibility Tests General Surgery Implantation Devices Biocompatibility Tests Neurosurgical Implantation Devices Biocompatibility Tests Ophthalmic Implantation Device's Biocompatibility Tests Others Chemistry Test Chemical characterization (E&L) Analytical method development and validation Toxicological Risk Assessment and consulting Microbiology & Sterility Test Bioburden Determination Pyrogen & Endotoxin Testing Sterility Test & Validation Antimicrobial Testing Others Package Validation By Phase Preclinical Large animal research Biocompatibility Tests Chemistry Test Microbiology & Sterility Test Small animal research Biocompatibility Tests Chemistry Test Microbiology & Sterility Test Clinical By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: Immediate Delivery Available | Buy This Premium Research @ About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. You can place an order or ask any questions, please feel free to contact us at sales@ Europe Region: +44 778 256 0738 North America Region: +1 8044 4193 44 APAC Region: +91 9356 9282 04 Web: Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hill
21 minutes ago
- The Hill
Mr. Trump, leave the Smithsonian alone
President Trump — who regularly denounces anything he dislikes as 'fake news,' even when it is accurate — is now demanding that Smithsonian Institution museums undergo an overhaul to present a fake version of history that erases America's flaws. This is a dangerous assault on truth, the type of action authoritarian rulers take. It sounds like something out of George Orwell's dystopian novel '1984,' where a totalitarian regime censors the news to distort the present and destroys historical records to rewrite the past to conform to the views of the all-powerful dictator known as Big Brother. Trump, who seems to act as if he wants to be the Big Brother of 2025, has appointed himself America's chief arbiter of what is fit to display in national museums. Like the authoritarian leaders he envies for their unchecked power, Trump has a boundless desire to exercise unchallenged control over every aspect of life in his country. This is why he demands to dictate not just what the Smithsonian displays, but what the news media reports, by filing lawsuits and restricting their access to him; what foreign leaders do, by imposing tariffs on their countries; and what universities teach, by withholding billions of dollars in federal funds. It is also why he has sent National Guard troops into the streets of Washington and Los Angeles to deal with non-existent emergencies, and launched what he calls the largest deportation program in American history against unauthorized immigrants. Republicans who control the House and Senate have disgracefully abdicated their responsibility to act as a check and balance on Trump's power grab. With their complicity, we are now essentially living in an authoritarian democracy — at least until the Democrats control one of those houses. Trump is demanding that the Smithsonian museums present the story of America and the world as he would like to see it, rather than as it really is. The president's version of history portrays the U.S. as exceptional and great. He wants to whitewash flaws such as slavery and discrimination against Black Americans, confiscation of Native American lands in violation of treaty obligations, the unprovoked war against Mexico that conquered what is now the western U.S., the internment of Japanese Americans during World War II, the denial of voting rights and other rights to women for much of our history — and more. In an Aug. 12 letter to Smithsonian Secretary Lonnie Bunch, administration officials demanded a 'comprehensive internal review' of eight Smithsonian museums by the White House 'to ensure alignment with the President's directive to celebrate American exceptionalism, remove divisive or partisan narratives, and restore confidence in our shared cultural institutions.' The review will cover current and planned museum exhibits, 'with particular attention to those planned for the 250th anniversary of the Declaration of Independence' in 2026. It will also examine 'websites, educational materials, and digital and social media content to assess tone, historical framing, and alignments with American ideals.' The letter is a follow-up to an executive order Trump issued in March denouncing 'a concerted and widespread effort to rewrite our nation's history … as inherently racist, sexist, oppressive, or otherwise irredeemably flawed.' In the order, Trump said Vice President JD Vance would head an effort to 'remove improper ideology' from all Smithsonian museums, research centers and the National Zoo. What is an 'improper ideology'? Apparently, whatever Trump says it is. The administration's letter calls for the museums to submit material documenting what is in their collections and says that, within 120 days, 'museums should begin implementing content corrections where necessary, replacing divisive or ideologically driven language with unifying, historically accurate and constructive descriptions.' We do not need this kind of Orwellian control by political appointees in government to determine how the Smithsonian museums should explain history, science and art. The museums are staffed by nonpartisan, career subject-matter experts. Trump — who demands an end all diversity, equity and inclusion initiatives — has already shown he wants to distort American history by denying the existence of systemic racism and downplaying the injustice of slavery and its legacy. Yet the National Museum of African American History and Culture is focused on telling the story of how racism has oppressed Black Americans, as well as highlighting the many achievements of Black people in government, education, science, business, entertainment, sports and other fields. It is a national treasure that tells a story all Americans should learn. No president should be able to dictate to the African American museum — or any other museum — what it should exhibit. In addition to politicizing what information is presented by some of the finest museums in the world, Trump's interference in the Smithsonian sets a terrible and costly precedent. Will the museums have to spend millions of dollars redesigning their exhibits every time a new president takes office to meet an ideological purity test? I agree with Trump that America is the greatest nation on Earth. I feel blessed to live here. But America is not and never has been perfect. No nation is. The president has an incredibly long list of vital tasks to perform. Overseeing the exhibits at the Smithsonian museums in not one of them. We do not need a curator-in-chief sitting in the Oval Office.
